Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Travis J Carlson

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Expert Opinion on Investigational Drugs|February 16, 2019
Ridinilazole for the treatment of Clostridioides difficile infectionTravis J Carlson, Bradley T Endres, Eugénie Bassères, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 3, 2023
The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective studyDenise Marie A Francisco, Laila Woc-Colburn, Travis J Carlson, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
<i>Clostridioides difficile</i> Infection Treatment and Outcome Disparities in a National Sample of United States HospitalsEric H Young, Kelsey A Strey, Grace C Lee, et al.
Disaster Medicine and Public Health Preparedness|March 27, 2025
Efficacy of Healthcare Student-Led Stop the Bleed Training for Middle School StudentsLorenzo Canseco, Abigail Johnson, Jonathan Mathews, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
National Disparities in Antibiotic Prescribing by Race, Ethnicity, Age Group, and Sex in United States Ambulatory Care Visits, 2009 to 2016Eric H Young, Kelsey A Strey, Grace C Lee, et al.
Journal of Pharmacy Practice|July 23, 2019
Significant Publications on Infectious Diseases Pharmacotherapy in 2018Jovan Borjan, Anne J Gonzales-Luna, Travis J Carlson, et al.
Open Forum Infectious Diseases|October 14, 2021
Corticosteroids Do Not Increase the Likelihood of Primary <i>Clostridioides difficile</i> Infection in the Setting of Broad-Spectrum Antibiotic UseTravis J Carlson, Anne J Gonzales-Luna, Melissa F Wilcox, et al.
Open Forum Infectious Diseases|November 19, 2020
Assessment of Kidney Injury as a Severity Criteria for <i>Clostridioides Difficile</i> InfectionTravis J Carlson, Anne J Gonzales-Luna, Kimberly Nebo, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trialJinhee Jo, Travis J Carlson, Chenlin Hu, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2020
<i>In Vitro</i> Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficileKhurshida Begum, Eugénie Bassères, Julie Miranda, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Expert Opinion on Investigational Drugs|February 16, 2019
Ridinilazole for the treatment of Clostridioides difficile infectionTravis J Carlson, Bradley T Endres, Eugénie Bassères, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|March 3, 2023
The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective studyDenise Marie A Francisco, Laila Woc-Colburn, Travis J Carlson, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
<i>Clostridioides difficile</i> Infection Treatment and Outcome Disparities in a National Sample of United States HospitalsEric H Young, Kelsey A Strey, Grace C Lee, et al.
Disaster Medicine and Public Health Preparedness|March 27, 2025
Efficacy of Healthcare Student-Led Stop the Bleed Training for Middle School StudentsLorenzo Canseco, Abigail Johnson, Jonathan Mathews, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
National Disparities in Antibiotic Prescribing by Race, Ethnicity, Age Group, and Sex in United States Ambulatory Care Visits, 2009 to 2016Eric H Young, Kelsey A Strey, Grace C Lee, et al.
Journal of Pharmacy Practice|July 23, 2019
Significant Publications on Infectious Diseases Pharmacotherapy in 2018Jovan Borjan, Anne J Gonzales-Luna, Travis J Carlson, et al.
Open Forum Infectious Diseases|October 14, 2021
Corticosteroids Do Not Increase the Likelihood of Primary <i>Clostridioides difficile</i> Infection in the Setting of Broad-Spectrum Antibiotic UseTravis J Carlson, Anne J Gonzales-Luna, Melissa F Wilcox, et al.
Open Forum Infectious Diseases|November 19, 2020
Assessment of Kidney Injury as a Severity Criteria for <i>Clostridioides Difficile</i> InfectionTravis J Carlson, Anne J Gonzales-Luna, Kimberly Nebo, et al.
The Journal of Antimicrobial Chemotherapy|August 12, 2025
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trialJinhee Jo, Travis J Carlson, Chenlin Hu, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2020
<i>In Vitro</i> Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficileKhurshida Begum, Eugénie Bassères, Julie Miranda, et al.
Pageof 3